Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III - Wikidata - wikimedia - TriplyDB

Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III

Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III

http://www.wikidata.org/entity/Q24300252

about

Lipoprotein genotype and conserved pathway for exceptional longevity in humans Apolipoprotein C3 SstI polymorphism and triglyceride levels in Asian Indians Mitogen-activated protein kinase regulates transcription of the ApoCIII gene. Involvement of the orphan nuclear receptor HNF4 A broad role for the zinc finger protein ZNF202 in human lipid metabolism Transcriptional regulation of apolipoprotein C-III gene expression by the orphan nuclear receptor RORalpha GPIHBP1 stabilizes lipoprotein lipase and prevents its inhibition by angiopoietin-like 3 and angiopoietin-like 4 An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms Regulation of hepatic ApoC3 expression by PGC-1β mediates hypolipidemic effect of nicotinic acid Antagonism between apolipoprotein AI regulatory protein 1, Ear3/COUP-TF, and hepatocyte nuclear factor 4 modulates apolipoprotein CIII gene expression in liver and intestinal cells Associations among race/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy.The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia The roles of genetic polymorphisms and human immunodeficiency virus infection in lipid metabolism New Era of Lipid-Lowering Drugs ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors reduce serum triglyceride levels through modulation of apolipoprotein C-III and lipoprotein lipase The genetics of serum lipid responsiveness to dietary interventions.Mass spectrometric identification of aberrantly glycosylated human apolipoprotein C-III peptides in urine from Schistosoma mansoni-infected individuals Liver proteomic response to hypertriglyceridemia in human-apolipoprotein C-III transgenic mice at cellular and mitochondrial compartment levels Identification of proteomic biomarkers in maternal plasma in the early second trimester that predict the subsequent development of gestational diabetes.Interactions of the apolipoprotein C-III 3238C>G polymorphism and alcohol consumption on serum triglyceride levels Orphan nuclear hormone receptor Rev-erbalpha regulates the human apolipoprotein CIII promoter.Apolipoprotein B genetic variants modify the response to fenofibrate: a GOLDN study.Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates APOA5 Q97X mutation identified through homozygosity mapping causes severe hypertriglyceridemia in a Chilean consanguineous family.Mapping O-glycosylation of apolipoprotein C-III in MALDI-FT-ICR protein profiles.Relationship between adiposity and cardiovascular risk factors in prevalent hemodialysis patients.A novel apolipoprotein C-II mimetic peptide that activates lipoprotein lipase and decreases serum triglycerides in apolipoprotein E-knockout mice Vertical sleeve gastrectomy restores glucose homeostasis in apolipoprotein A-IV KO mice.PPAR-alpha effects on the heart and other vascular tissues.Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype Apolipoprotein A1/C3/A5 haplotypes and serum lipid levels The contribution of individual and pairwise combinations of SNPs in the APOA1 and APOC3 genes to interindividual HDL-C variability Lowering triglycerides to modify cardiovascular risk: will icosapent deliver?Maternal inheritance of severe hypertriglyceridemia impairs glucose metabolism in offspring.Isotretinoin and FoxO1: A scientific hypothesis.Associations of the APOC3 rs5128 polymorphism with plasma APOC3 and lipid levels: a meta-analysis The Association of Human Apolipoprotein C-III Sialylation Proteoforms with Plasma Triglycerides Apolipoprotein C-III: a potent modulator of hypertriglyceridemia and cardiovascular disease.Tryptophan probes reveal residue-specific phospholipid interactions of apolipoprotein C-III Dose-response effects of marine omega-3 fatty acids on apolipoproteins, apolipoprotein-defined lipoprotein subclasses, and Lp-PLA2 in individuals with moderate hypertriglyceridemia.

P2860

223c10cb5c268544a8dd235b64ad6407a32ad463 50bf38cecf2a98bf9b3cb3983b783b6ef1802b3f 6963a992886309861a1bf5a8decefa25682939c6 ac33c8aa940c4cdec2b7eb34b906ebe7d8de0303 b1beebac60fa9287e5714597e6acfebb9d9c32d5 e531af3fc6c1e6ef454732c3b055c88a76a3475d ede39d74e1bc28ba558b4395ae7223837690f9bd f5274bef7bf8168cbf06bc9f08de77ef8fa66b48

P248

Q21146060-6DEFECDF-5DBF-43DE-91EF-172E6056B3FD Q21283798-9B9D510F-8A52-4A23-82F6-9990B4542EB9 Q22010768-237E5034-B69D-46C3-8282-D6D888F6B43F Q22253447-889BB30E-6F7B-4FA0-881F-CF6BC174547B Q24290442-60AA836E-BD18-4B66-8BDB-189F98F29BB4 Q24338849-3CE58F24-527C-4864-9138-66FAFF56631B Q24562942-B8FDB4C9-94D0-4A6A-884B-BC85C1C97152 Q24594113-939AADBF-ADB0-4E42-9573-237DDF56AA46 Q24606324-C8F61BD6-63E6-4C31-9A9B-94638C16B631 Q25255216-93DA7D36-3BB8-46D0-AB1A-C9D64CAA442F Q26864682-9C547891-A537-442E-86E9-6B2C789FBE1B Q27021950-2A503254-A122-4791-86E1-F37C70C0B1BB Q28072298-B54F28B1-57E9-49D4-8829-440ED1D506FE Q28505778-5985389A-A87E-48DC-8CC9-B4F2CFEDE1E3 Q28572175-C477397C-29DB-421C-AC8A-BBAE6A0A7556 Q33644526-0D0A113A-7D0E-439C-9A3D-D80CB057E1E9 Q33812839-27296309-D785-4E7A-B62A-E162AA05D428 Q33958622-2B4807D6-8DFA-45D3-846A-89376E08A3C6 Q34078908-2EFDA56C-53F0-45C3-8980-FBABB846BF94 Q34088158-9FE97F0F-7839-4C6B-8FAF-94CC3BDC595F Q34129395-755F3607-7B15-446E-BCC1-91C6355F2126 Q34188082-11D68399-987D-4636-9B50-E60ACA20764C Q34201490-92B3DFE2-1C35-405F-8F39-A7F4746AB46C Q34476810-A2C4CA01-FD4B-4660-A734-DB17B499380E Q34555445-32A82AD0-91B7-4B9C-BA20-C890346EFE6F Q34570994-23349C45-5FFA-4830-BD39-DEAFF4B807CD Q34946523-AA1196F2-03A0-4939-96D8-9D90DAE0DBA2 Q35004370-8132A06A-ED39-44C2-9EC4-DD2435EC7A9B Q35080447-4A5456AC-9357-4C63-8917-F3ECC7F8DF9F Q35157797-34B63297-3717-4BD6-A541-312F2D337825 Q35206176-D884F3D7-BDE8-4B4D-B94D-4248E57F4786 Q35222189-6FFAB401-6F60-4955-A672-E220ABD6586A Q35230819-507AAA52-8A22-4400-8DAB-B422B1EDB0FD Q35310272-2B915469-B8B1-40B6-96F2-986A11D17BF1 Q35558873-1B147548-855F-45BE-9C5A-3BA8C3CE271D Q35687045-95D85920-3D01-41BB-8067-1FDF286A623F Q35860314-6B4D38A6-E0CF-4ACE-BB50-88515F8DCCE2 Q35915137-57925BF1-3D61-43E0-9556-8ED60A143EB1 Q36137606-98204844-061E-487D-BADF-A6B24E0351D8 Q36368459-F3FD2957-1A03-455B-9408-906EC0CEED6D

P2860

Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III

http://www.wikidata.org/entity/Q24300252

description

1985 nî lūn-bûn

@nan

1985 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

1985 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

1985年の論文

@ja

1985年論文

@yue

1985年論文

@zh-hant

1985年論文

@zh-hk

1985年論文

@zh-mo

1985年論文

@zh-tw

1985年论文

@wuu

name

Modulation of lipoprotein lipa ...... Effect of apolipoprotein C-III

@ast

Modulation of lipoprotein lipa ...... Effect of apolipoprotein C-III

@en

Modulation of lipoprotein lipa ...... Effect of apolipoprotein C-III

@en-gb

Modulation of lipoprotein lipa ...... Effect of apolipoprotein C-III

@nl

type

label

Modulation of lipoprotein lipa ...... Effect of apolipoprotein C-III

@ast

Modulation of lipoprotein lipa ...... Effect of apolipoprotein C-III

@en

Modulation of lipoprotein lipa ...... Effect of apolipoprotein C-III

@en-gb

Modulation of lipoprotein lipa ...... Effect of apolipoprotein C-III

@nl

prefLabel

Modulation of lipoprotein lipa ...... Effect of apolipoprotein C-III

@ast

Modulation of lipoprotein lipa ...... Effect of apolipoprotein C-III

@en

Modulation of lipoprotein lipa ...... Effect of apolipoprotein C-III

@en-gb

Modulation of lipoprotein lipa ...... Effect of apolipoprotein C-III

@nl

P1433

Q24300252-FD86E3EF-ACBA-4965-A8AD-62D31483ED37

P1476

Q24300252-C50AA693-E9D4-456F-900C-4194EA08CE98

P2093

Q24300252-451BC3B1-C689-4062-8FDC-C9E2AEF33C00

Q24300252-6F9D346F-0EB6-48CD-8752-63A8F1360720

Q24300252-9138C8FA-EDFD-4870-846C-904EC5646F9C

Q24300252-DA3DBF68-9300-4857-8630-865693566E3A

P2860

Q24300252-0639BFCB-F2BD-4E05-8BA8-151742B76DDA

Q24300252-10B043D8-F208-44E8-8000-E64596EFB186

Q24300252-32A750C3-5227-40BF-96BC-133C9BC6BEF5

Q24300252-5B2F63D1-3D6B-428C-A208-DA666352269D

Q24300252-6974AE14-8CA4-4D69-9513-5F6D0A16043E

Q24300252-738C4585-2085-4CB6-B549-567C3BA89EA5

Q24300252-8D91712D-7B99-441D-9FBB-6AEC9EB29B4C

Q24300252-97C36839-0CEF-413F-91F0-8D0A3DB3E3CB

Q24300252-A4CB29C7-DC66-4468-A5B9-26400EEAC797

Q24300252-A895708D-E129-4420-AF34-D5EC891B11C0

P304

Q24300252-1EF94159-F58D-41C3-A6D2-5B13404DF07F

P31

Q24300252-33DB59A7-D04A-4524-BAA0-D0B4C3E91C5F

P356

Q24300252-064A3657-D178-41F5-B00C-8B4ED6548D8B

P407

Q24300252-A4E0D6A9-F939-4650-ABBD-C4D890F34258

P433

Q24300252-E3DD7F77-8E8C-48B6-97B9-B5D5C4918F38

P478

Q24300252-3CEE72F5-FD15-46FB-8E5D-80BBDC697CAD

P577

Q24300252-109FCD83-1440-4460-A99B-0F4C4891B813

P5875

Q24300252-848B68A2-FB52-4C40-8CBA-03F9DDF6E0ED

P698

Q24300252-6919F94E-E40D-4728-8295-60983B364BDC

P921

Q24300252-17EAF412-8D17-4A4A-A942-AA508A884D01

Q24300252-3A97232B-42DB-4974-8142-B445996769C2

Q24300252-436A4F8B-DC87-4FE5-9786-F1D77062986D

Q24300252-DDAF9DBB-E4F1-4498-8DBE-E453083102AC

P932

Q24300252-6EC002F2-1A2C-4E29-B860-E926BE7ED4FD

P356

P1433

Journal of Clinical Investigation

P1476

Modulation of lipoprotein lipa ...... Effect of apolipoprotein C-III

@en

P2093

C S Wang

http://www.w3.org/2001/XMLSchema#string

H U Kloer

http://www.w3.org/2001/XMLSchema#string

P Alaupovic

http://www.w3.org/2001/XMLSchema#string

W J McConathy

http://www.w3.org/2001/XMLSchema#string

P2860

Protein measurement with the Folin phenol reagent

The complete amino acid sequence of alanine apolipoprotein (apoC-3), and apolipoprotein from human plasma very low density lipoproteins

Linkage of human apolipoproteins A-I and C-III genes

Quantitative determination of apolipoproteins C-I and C-II in human plasma by separate electroimmunoassays

Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein

Isolation and partial characterization of a new acidic apolipoprotein (apolipoprotein F) from high density lipoproteins of human plasma.

Selective measurement of two lipase activities in postheparin plasma from normal subjects and patients with hyperlipoproteinemia.

Transport of very low density lipoprotein triglycerides in varying degrees of obesity and hypertriglyceridemia.

Lipoprotein lipase.

Changing relative proportions of apolipoproteins CII and CIII of very low density lipoproteins in hypertriglyceridaemia.

P304

384-90

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI111711

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

75

http://www.w3.org/2001/XMLSchema#string

P577

1985-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

19188953

http://www.w3.org/2001/XMLSchema#string

P698

3973011

http://www.w3.org/2001/XMLSchema#string

P921

very-low-density lipoprotein particle remodeling

Apolipoprotein C3

Lipoprotein lipase

P932

423500

http://www.w3.org/2001/XMLSchema#string